Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials

ClinicalLIVEUpdated 18 Nov 2026

New Clinical Trials

Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.

Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.

Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777

Signals

What the register says this week, and why it matters if you sell into it.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
  3. 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
  4. A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

Export the full new clinical trials

777 rows as a .csv. Free. Every field, with its source link.

Country
Phase
Study type
777 / 777 trials
PostedSponsorStudyPhaseStatus
27 Oct 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Study to Evaluate the Pharmacokinetic Characteristics of HS-20118 Under Different Dosing Conditions in Healthy ParticipantsPhase 1Active Not Recruiting27 Oct 2026MED-EL Elektromedizinische Geräte GmbHAustria, Belgium, GermanyMi2000 TICI - Post-market Implantation StudyNot applicableRecruiting27 Oct 2026Medsyn Biopharma, LLCA Study of MDSY-1240, a STAT3 Degrader, for the Treatment of Hematologic Malignancies and Advanced Solid TumorsPhase 1, Phase 2Not Yet Recruiting27 Oct 2026Metaclipse Therapeutics CorporationUnited StatesTMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell CarcinomaPhase 1Recruiting27 Oct 2026NovaResp Technologies IncCanadaTesting Settings of NovaResp's cMAP® Software During Home PAP TherapyNot applicableNot Yet Recruiting27 Oct 2026Novartis PharmaceuticalsFactors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and RwandaNot Yet Recruiting27 Oct 2026Otto Bock Healthcare Products GmbHUnited States, GermanyEvaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple SclerosisNot applicableNot Yet Recruiting27 Oct 2026PfizerUnited States, Puerto RicoA Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid TumorsPhase 1Not Yet Recruiting27 Oct 2026PfizerA Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older AdultsPhase 1Not Yet Recruiting27 Oct 2026PfizerUnited StatesA Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different HistologiesActive Not Recruiting27 Oct 2026Pneumagen Ltd, a subsidiary of NorthLinks BioUnited KingdomNasal Residency of HEX17Phase 1Not Yet Recruiting27 Oct 2026RashEndZ Inc.United StatesSafety and Efficacy of RashEndZ Wound Aeration TechnologyNot applicableTerminated27 Oct 2026SanofiUnited Arab EmiratesA Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world SettingRecruiting27 Oct 2026Shaanxi Giant Biotechnology Co., LtdChinaRecombinant Collagen Freeze-Dried Fibre for Upper Facial WrinklesNot applicableCompleted27 Oct 2026Swedish Orphan BiovitrumBrazil, Canada, FinlandA Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsPhase 3Recruiting27 Oct 2026T-MAXIMUM Pharmaceutical IncUnited States, TaiwanThe METAMAX Study: MT027 Allogeneic CAR-T for Brain Metastases From Advanced Solid TumorsPhase 2Not Yet Recruiting27 Oct 2026Tango Therapeutics, Inc.TNG462-C103: Study to Evaluate the Safety, Tolerability, and Antitumor Activity of Vopimetostat in Combination With ERAS-0015 in PDAC and NSCLC PatientsPhase 1, Phase 2Not Yet Recruiting27 Oct 2026Triastek, lnc.ChinaA Food-Effect Study of Budesonide Delayed Release Tablet (D23A) in Healthy Chinese ParticipantsPhase 1Not Yet Recruiting26 Oct 2026AbbVieA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Alveltamig and Atezolizumab for Adults Participants With Extensive Stage-Small Cell Lung CancerPhase 2Not Yet Recruiting26 Oct 2026AbbVieA Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) ABBV-706 in Combination With Tarlatamab and Atezolizumab in Adult Participants With Extensive Stage-Small Cell Lung CancerPhase 2Not Yet Recruiting26 Oct 2026AeroRx Therapeutics Inc.United KingdomPhase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD PatientsPhase 2Recruiting26 Oct 2026BeOne MedicinesAn Investigational Study of BON-106 in Adults With Advanced or Metastatic Solid TumorsPhase 1Not Yet Recruiting26 Oct 2026BioligentUnited StatesA Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.Not applicableRecruiting26 Oct 2026BYHEALTH Co., LTDChinaStudy on the Effects of Probiotic on Infant Gut Microbiota and Immune RegulationNot applicableCompleted26 Oct 2026Changchun BCHT Biotechnology Co.ChinaA Phase II Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)Phase 2Recruiting26 Oct 2026ChinaNormChinaPre- and Post-procedure Skin Knowledge StudyNot applicableRecruiting26 Oct 2026CochlearSpainEffect of a Totally Implantable Cochlear Implant on Tinnitus Severity in Adults With Preoperative TinnitusNot applicableNot Yet Recruiting26 Oct 2026Editas Medicine, Inc.AustraliaEDIT-401 in Adults Who Require Additional Lowering of Low-Density Lipoprotein Cholesterol (LDL-C)Phase 1, Phase 2Not Yet Recruiting26 Oct 2026F2G LtdManaged Access Program Allowing Access to OlorofimAvailable26 Oct 2026GE HealthcareFinlandClinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor CableRecruiting26 Oct 2026Givaudan France NaturalsThe Effect of a Ginger Formula on Menstrual Health vs a PlaceboNot applicableNot Yet Recruiting26 Oct 2026HALEONCanadaA Study to Assess the Efficacy of a Calcium Sodium Phosphosilicate Toothpaste for the Relief of Dentine HypersensitivityNot applicableRecruiting26 Oct 2026Healthgen Biotechnology Corp.Efficacy and Safety of OsrhCT Before Upper Endoscopy on Improving Visualization of the Gastric Mucosa.Phase 2Not Yet Recruiting26 Oct 2026Hiya HealthUnited StatesA Clinical Trial to Evaluate the Effects of a Children's Daily Multivitamin on Perceived Growth, Immune Health, Energy, and Focus in ChildrenNot applicableRecruiting26 Oct 2026InventisBio Yiqi Beijing LimitedA Study to Evaluate YF550 in Participants With Locally Advanced or Metastatic Solid Tumors.Phase 1Not Yet Recruiting26 Oct 2026Jeil Pharmaceutical Co., Ltd.South KoreaPost-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan CitrateRecruiting26 Oct 2026Jiangsu HengRui Medicine Co., Ltd.ChinaA Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast CancerPhase 3Not Yet Recruiting26 Oct 2026Jubaan Ltd.United StatesEvaluation of Gixam's Repeatability and Reproducibility Predicting the Presence of Advanced and Non-Advanced Colorectal NeoplasiaNot applicableNot Yet Recruiting26 Oct 2026Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.ChinaPhase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic DermatitisPhase 2Recruiting26 Oct 2026Merck Sharp & Dohme LLCA Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)Phase 2Not Yet Recruiting26 Oct 2026MNnutraUnited StatesA Study to Evaluate the Effects of a Dietary Supplement on Weight Management and Appetite ControlNot applicableActive Not Recruiting26 Oct 2026NeuEveUnited StatesA Clinical Trial to Evaluate the Effects of the NeuEve Dryness Treatment Kit on Vaginal Health, Comfort, and Quality of Life in Postmenopausal WomenNot applicableNot Yet Recruiting26 Oct 2026Novo Nordisk A/SGermanyA Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesPhase 1Recruiting26 Oct 2026Nuwacell Biotechnologies Co., Ltd.ChinaA Phase 1 Study of NCR201 in Parkinson's Disease Patients With Prior DBSPhase 1Not Yet Recruiting26 Oct 2026Qilu Pharmaceutical Co., Ltd.QLC5508 vs. Investigator's Choice Chemotherapy in Advanced Extrapulmonary Neuroendocrine CarcinomaPhase 3Not Yet Recruiting26 Oct 2026Regeneron PharmaceuticalsEfficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without DiabetesPhase 3Not Yet Recruiting26 Oct 2026RemeGen Co., Ltd.ChinaPhase II Clinical Study of RC148 (ABBV-1480) in Combination With Telisotuzumab Adizutecan (With or Without Chemotherapy) for Unresectable Colorectal CancerPhase 2Not Yet Recruiting26 Oct 2026SanofiUnited StatesA Study to Describe Patient REal-world FitusiRan ExpeRienceNot Yet Recruiting26 Oct 2026Suzhou Suncadia Biopharmaceuticals Co., Ltd.ChinaSHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III StudyPhase 3Not Yet Recruiting26 Oct 2026Suzhou Suncadia Biopharmaceuticals Co., Ltd.ChinaA Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung CancerPhase 3Not Yet Recruiting

// How AOS uses this

Every row here is a potential account. AOS finds the ones that need what you sell, maps the decision makers and prepares the outreach for your approval.